Seagen to Report First Quarter 2023 Financial Results on April 27, 2023
BOTHELL, Wash.–(BUSINESS WIRE)–
Seagen Inc. (Nasdaq: SGEN) today announced that it will report its first quarter 2023 financial results on Thursday, April 27, 2023.
Given the recently announced agreement to be acquired by Pfizer Inc., Seagen will not be hosting a conference call.
About Seagen
Seagen is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. For more information on the company’s marketed products and robust pipeline, visit www.seagen.com and follow @SeagenGlobal on Twitter.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230407005028/en/
For Investors
Douglas Maffei, Ph.D.
Vice President, Investor Relations
(425) 527-4881
[email protected]
For Media
David Caouette
Vice President, Corporate Communications
(310) 430-3476
[email protected]
KEYWORDS: Washington United States North America
INDUSTRY KEYWORDS: Oncology Health Clinical Trials Research Science Pharmaceutical Biotechnology
MEDIA:
| Logo |
 |